GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (STU:ABG) » Definitions » Earnings per Share (Diluted)

Cencora (STU:ABG) Earnings per Share (Diluted) : €6.92 (TTM As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cencora Earnings per Share (Diluted)?

Cencora's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was €0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €6.92.

Cencora's EPS (Basic) for the three months ended in Sep. 2024 was €0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was €6.99.

Cencora's EPS without NRI for the three months ended in Sep. 2024 was €3.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was €12.26.

During the past 12 months, Cencora's average EPS without NRIGrowth Rate was 14.80% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 15.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 17.40% per year.

During the past 13 years, Cencora's highest 3-Year average EPS without NRI Growth Rate was 59.50% per year. The lowest was -12.20% per year. And the median was 18.30% per year.


Cencora Earnings per Share (Diluted) Historical Data

The historical data trend for Cencora's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Earnings per Share (Diluted) Chart

Cencora Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.14 6.28 8.12 7.99 6.79

Cencora Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.61 2.73 1.92 2.25 0.02

Competitive Comparison of Cencora's Earnings per Share (Diluted)

For the Medical Distribution subindustry, Cencora's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's PE Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's PE Ratio falls into.



Cencora Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Cencora's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2024 is calculated as

Diluted Earnings Per Share (A: Sep. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1359.717-0)/200.284
=6.79

Cencora's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2024 is calculated as

Diluted Earnings Per Share (Q: Sep. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(3.047-0)/198.061
=0.02

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Cencora  (STU:ABG) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cencora Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Cencora's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora Business Description

Traded in Other Exchanges
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.